Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Novo Nordisk Pharma Operations A/S

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 161,242 More Arrow 316,416 Less Arrow 135,643
Earnings before taxes 10,072 Less Arrow 7,152 Less Arrow 6,048
Total assets 115,942 More Arrow 203,148 Less Arrow 97,451
Current assets 103,931 Less Arrow 83,318 Less Arrow 82,297
Current liabilities 52,719 Less Arrow 52,313 More Arrow 58,439
Equity capital 43,064 More Arrow 107,311 Less Arrow 28,245
- share capital 744 More Arrow 748 Less Arrow 688
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 37.1% More Arrow 52.8% Less Arrow 29.0%
Turnover per employee
Profit as a percentage of turnover 6.2% Less Arrow 2.3% More Arrow 4.5%
Return on assets (ROA)
Current ratio 197.1% Less Arrow 159.3% Less Arrow 140.8%
Return on equity (ROE) 23.4% Less Arrow 6.7% More Arrow 21.4%
Change turnover -153,554 More Arrow 168,818 Less Arrow 26,726
Change turnover % -49% More Arrow 114% Less Arrow 25%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.